Persistent Challenges of HIV Transmission Control in Injection Drug Use: Lessons From the Indiana Outbreak
Tuesday, February 16, 2016
1:00 PM (ET), 12:00 PM (CT), 11:00 AM (MT), 10:00 AM (PT)
Assessment of Needs
The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will address the HIV epidemic that occurred in Indiana last year. To date, this is the largest outbreak of HIV infection related to injection drug use to have occurred in a rural setting in the United States. Federal, state, academic and local partners all significantly contributed to the massive response undertaken to control the epidemic in its early stages. Assessment of the on-going efforts to achieve individual and community-wide virologic suppression demonstrates persistent challenges in optimal engagement at each stage of the care continuum.
On completion of this IAS–USA live activity, participants will be able to:
- Describe the HIV outbreak in rural Indiana
- List interventions taken to stop the outbreak
- Identify key elements for HIV treatment in a rural outbreak
Who Should Attend
This webinar is designed for physicians who are actively treating or will be treating patients with HIV infection.
This activity is also relevant for other practitioners, including nurse practitioners and other nursing professionals, physician assistants, and pharmacists.
Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.
Registration closes on Monday, February 15, 2016, 4:00 PM (PT).
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is eligible for ANCC credit, see final CNE activity announcement for specific details.
This activity is eligible for ACPE credit, see final CPE activity announcement for specific details.
Requests for educational grants have been made to commercial companies with competing products. Information on grant support will be posted on the IAS–USA website as it becomes available.
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.